Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms.

@article{Gavins2003LeukocyteAA,
  title={Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms.},
  author={Felicity N. E. Gavins and Simon Yona and Ahmad M. Kamal and Roderick John Flower and Mauro Perretti},
  journal={Blood},
  year={2003},
  volume={101 10},
  pages={
          4140-7
        }
}
Recent investigations conducted with human neutrophils have indicated an involvement for the receptor for formylated peptides, termed FPR, and its analog FPRL1 (or ALXR because it is the receptor for the endogenous ligand lipoxin A(4)) in the in vitro inhibitory actions of the glucocorticoid-regulated protein annexin 1 and its peptidomimetics. To translate these findings in in vivo settings, we have used an ischemia/reperfusion (I/R) procedure to promote leukocyte-endothelium interactions in… 

Figures and Tables from this paper

Anti-Inflammatory Role of the Murine Formyl-Peptide Receptor 2: Ligand-Specific Effects on Leukocyte Responses and Experimental Inflammation
TLDR
The creation of a novel mouse colony in which the murine FprL1 FPR2 homologue, Fpr2, has been deleted is reported and its use to explore the biology of this receptor is described, concluding that Fpr 2 is an anti-inflammatory receptor that serves varied regulatory functions during the host defense response.
Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement.
TLDR
Findings demonstrate for the first time distinct mechanisms of action for ANXA1 and its N-terminal peptide Ac2-26, which inhibited firm adhesion of human PMNs and significantly attenuated capture and rolling without effect on firmAdhesion.
Annexin-1 is an endogenous gastroprotective factor against indomethacin-induced damage.
TLDR
It is proposed that in some circumstances, annexin-1 plays an important role as an endogenous mediator of mucosal defense and mediates the gastroprotective effects of a glucocorticoid against NSAID-induced damage.
Functional and ultrastructural analysis of annexin A1 and its receptor in extravasating neutrophils during acute inflammation.
TLDR
In vivo support is provided to the hypothesis that endogenous AnxA1 is an essential effector of endogenous anti-inflammation and an ultrastructural indication that this mediator interacts with Fpr2 in murine neutrophils is provided.
Evidence for an Anti-Inflammatory Loop Centered on Polymorphonuclear Leukocyte Formyl Peptide Receptor 2/Lipoxin A4 Receptor and Operative in the Inflamed Microvasculature
TLDR
Analysis of PMN degranulation patterns and phospho-AnxA1 status suggested a model in which the two FPR2/ALX agonists mobilize the cytosolic pool of Anx a1 through an intermediate phosphorylation step, which prompts the existence of an endogenous network in anti-inflammation centered on PMN AnxA 1 and activated by selective FPR 2/ALx agonists.
Design and characterization of a cleavage-resistant Annexin A1 mutant to control inflammation in the microvasculature.
TLDR
Results indicate that AnxA1 cleavage is an important process during neutrophilic inflammation and that controlling the balance between Anx A1/PR3 activities might represent a promising avenue for the discovery of novel therapeutic approaches.
A Novel Peptide Agonist of Formyl-Peptide Receptor-Like 1 (ALX) Displays Anti-Inflammatory and Cardioprotective Effects
TLDR
Collectively, these new data support a potential role for CGEN-855A in the treatment of reperfusion-mediated injury and in other acute and chronic inflammatory conditions.
Activation of the Annexin A1 Pathway Underlies the Protective Effects Exerted by Estrogen in Polymorphonuclear Leukocytes
TLDR
A novel AnxA1-dependent mechanism behind the inhibitory properties of estrogen on PMN activation is unveiled, describing a novel phenotype with a conceivable impact on the vasculoprotective effects of this hormone.
Fpr2/ALX Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation: Impact for Therapy in Cardiovascular Disease
TLDR
Fpr2/ALX is a therapeutic target for initiating endogenous proresolving, anti-inflammatory pathways following cerebral I/R injury and is found to regulate NPA formation in the brain and inhibited the reactivity of the cerebral microvasculature.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 52 REFERENCES
Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse. A qualitative comparison with an anti-CD11b monoclonal antibody.
TLDR
This study confirms the activity of LC1 in another model of experimental inflammation and suggests that it acts partly through inhibition of leukocyte activation with an overall effect qualitatively comparable to the blocking of CD11b portion of a beta 2-integrin complex.
Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin.
TLDR
In vivo superfusion of the rat mesentery with stable lipoxin analogs at 10 nmol/liter reduces L-NAME-induced leukocyte rolling and adherence in the mesenteric rat microvasculature by attenuating P-selectin expression, and this anti-inflammatory mechanism may represent a novel and potent regulatory action of lipoxins on the immune system.
A Potential Role for Annexin 1 as a Physiologic Mediator of Glucocorticoid-Induced L-Selectin Shedding from Myeloid Cells1
TLDR
It is shown that ANX1 induces a dose- and time-dependent decrease in L-selectin expression on both peripheral blood neutrophils and monocytes but has no effect on lymphocytes, which may provide the basis for further understanding of mechanisms involved in the down-regulation of inflammatory responses.
Activation of Lipoxin a4 Receptors by Aspirin-Triggered Lipoxins and Select Peptides Evokes Ligand-Specific Responses in Inflammation
TLDR
It is suggested that ALXR activation by LX or ATL can protect the host from potentially deleterious PMN responses associated with innate immunity as well as direct effector responses in tissue injury by recognition of peptide fragments.
Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor
TLDR
Together, these results indicate functional redundancies in endogenous lipid and peptide anti-inflammatory circuits that are spatially and temporally separate, where both ATL and specific ANXA1-derived peptides act in concert at ALXR to downregulate PMN recruitment to inflammatory loci.
Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration
TLDR
It is reported that LCI is mobilized and externalized following PMN adhesion to endothelial monolayers in vitro or to venular endothelium in vivo and that the end point of this process is a negative regulation of PMN transendothelial passage.
...
1
2
3
4
5
...